Kera Capital Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.1M Buy
43,876
+3,787
+9% +$883K 1.07% 20
2026
Q1
$9.8M Buy
40,089
+13,873
+53% +$3.23M 1.2% 16
2025
Q4
$5.96M Buy
26,216
+15,833
+152% +$3.13M 0.73% 33
2025
Q3
$1.93M Buy
10,383
+6,267
+152% +$1.07M 0.29% 59
2025
Q2
$629K Buy
4,116
+1,039
+34% +$160K 0.12% 70
2025
Q1
$510K Buy
3,077
+647
+27% +$101K 0.15% 64
2024
Q4
$351K Buy
+2,430
New +$377K 0.1% 74

Other funds holding JNJ

Kera Capital Partners's JNJ Position: Q2 2026 in Review

Kera Capital Partners increased its Johnson & Johnson (JNJ) stake by 9.4% in Q2 2026, buying an estimated $883K and bringing the position to 43,876 shares worth $11.1M. The position accounts for 1.07% of the portfolio, ranked #20.

Kera Capital Partners first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Kera Capital Partners held 43,876 shares of Johnson & Johnson worth $11.1M as of Q2 2026.
  • Kera Capital Partners bought 3,787 Johnson & Johnson shares in Q2 2026, an estimated $883K.
  • Johnson & Johnson made up 1.07% of Kera Capital Partners's portfolio in Q2 2026, its #20 holding.
  • Kera Capital Partners first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Kera Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.